52 results
Page 2 of 3
8-K
EX-99.1
we6hvzr3punmjy1
11 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
11:30am
425
EX-99.1
1wmr96vposb1 8ayajv
30 Aug 23
Business combination disclosure
7:30am
8-K
EX-99.1
e4z uwwqi8bz5
30 Aug 23
Graf Acquisition Corp. IV Announces Intent to Adjourn Special Meeting
7:30am
425
lbn cq2g7ipz
24 Aug 23
Business combination disclosure
8:15am
425
EX-99.1
2jl3 t4240
15 Aug 23
Business combination disclosure
4:31pm
8-K
EX-99.1
kusy9a
15 Aug 23
Graf Acquisition Corp. Iv and Nkgen Biotech, Inc. Announce Effectiveness of Form S-4 for Proposed Business Combination
4:30pm
424B3
jeuuz2s5bxbzd36vsl
14 Aug 23
Prospectus supplement
4:30pm
425
6t112b11lf0x
9 Aug 23
Business combination disclosure
2:05pm
425
EX-99.1
2z6cdglu8v3z1hbpx350
26 Jul 23
Business combination disclosure
11:55am
8-K
EX-99.1
8471zhbjfodpjx bds
26 Jul 23
For Investor Use Only For Investor Use Only Maximizing Immune Integrity Investor Event Presentation July 2023
11:54am
425
EX-99.1
iuwed
17 Jul 23
Business combination disclosure
8:00am
425
EX-99.2
d9y69l5z 5mjzy550vnw
17 Jul 23
Business combination disclosure
8:00am
8-K
EX-99.1
0lv4bjxhqnw0nth
17 Jul 23
NKGen Biotech Presents Interim Phase I Trial Data at 2023 Alzheimer’s Association International Conference
8:00am
8-K
EX-99.2
zcx64umg
17 Jul 23
NKGen Biotech Presents Interim Phase I Trial Data at 2023 Alzheimer’s Association International Conference
8:00am
425
allg0bxcjjw
6 Jul 23
Business combination disclosure
12:34pm
S-4/A
1cva1zzdlm7eg6a
26 Jun 23
Registration of securities issued in business combination transactions (amended)
5:02pm
425
EX-99.1
yxz3i
5 Jun 23
Business combination disclosure
8:32am